Day: November 5, 2020

Vancouver, Nov. 05, 2020 (GLOBE NEWSWIRE) — VANCOUVER, British Columbia – (November 5, 2020) Oroco Resource Corp. (TSX-V: OCO) (“Oroco” or “the Company”) is pleased to announce progress with a deep Three Dimensional (“3D”) Induced Polarization geophysical survey on the Santo Tomas property, Mexico, which is intended to map mineralized zones that contain chargeable metal sulphide minerals.The survey is being undertaken by DIAS Geophysical of Saskatoon, SK (“DIAS”) and utilizes their DIAS32 direct current resistivity and induced polarization (“DCIP”) system using a rolling layout of transmitter locations and a large receiver array that is advancing the survey in successive swaths from the south towards the north of the Santo Tomas mineralized zones.  The survey is targeted to cover an area of approximately 10 km2 of the Property which...

NORTH LIBERTY, Iowa, Nov. 05, 2020 (GLOBE NEWSWIRE) — Heartland Express, Inc. (www.heartlandexpress.com) (HTLD) was honored with a SmartWay Excellence Award from the U.S. Environmental Protection Agency as an industry leader in freight supply chain environmental performance and energy efficiency.Heartland Express’ industry leading age of fleet equipment directly contributes to the Company’s dedication to clean air and carbon footprint reduction. It has an ongoing commitment of continued investment in its fleet of tractors and technology. Heartland’s tractor fleet is equipped with aerodynamic technologies, idle management controls, and speed regulations. These items combined with out-of-route management, biodiesel purchasing, and maintenance efficiency practices all add to the sustainability of Heartland’s carbon footprint.“Our partnership...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONSOF THAT JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”) AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION RELATING TO TRYG A/S.FOR IMMEDIATE RELEASE5 November 2020RSA INSURANCE GROUP PLC (“RSA”) FURTHER STATEMENT REGARDING PROPOSALFurther to the announcement by RSA earlier today regarding an approach from Intact Financial Corporation (“Intact”) and Tryg A/S (“Tryg”) (together, the “Consortium”)...

Addresses Market Need for Two Factor Authentication Services – Already Deployed and Active Within Commercial Customer EnvironmentsRESEARCH TRIANGLE PARK, NC, Nov. 05, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (“Data443” or the “Company”) (OTCPK: ATDS), a leading data security and privacy software company, is pleased to announce the official release of another substantial enhancement for its flagship data transfer, transformation and delivery product, DataExpress® – which powers numerous Fortune 50 clients and will be available shortly in a SaaS format.What it is:DataExpress® Secure Managed File Transfer provides a broad capability of services to securely move data intra and inter company.Enhancement satisfies the request from a leading credit card aggregator, and long-term user of DataExpress®, for a Two Factor...

– Intranasal administration of NL-CVX1 protects hamsters from lethal SARS-CoV-2 infection –– Designed to resist viral mutational escape by mimicking the natural target of the spike protein –SEATTLE, Nov. 05, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2. This report details the creation of de novo protein decoys that were specifically designed to bind the SARS-CoV-2 spike protein with high affinity, preventing its association with the viral receptor hACE2, which is required for infection. The manuscript...

GLEN HEAD, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC), is proud to announce that The First National Bank of Long Island has been named to Newsweek magazine’s inaugural ranking of “America’s Best Banks 2021.”  In their first-ever ranking of financial institutions, Newsweek officially recognized the full-service commercial bank as the “Best Small Bank in New York State.”Newsweek partnered with LendingTree, the online loan marketplace and comparison site for financial services, to create the Best Banks rankings. By evaluating more than 2,500 FDIC-insured financial institutions, they assessed U.S. banks by looking at 55 separate elements of loans, and savings and checking accounts to determine “best-in-class” options across 19 categories, including the best big and small bank...

Mündlicher Vortrag zur Erörterung der Ergebnisse der von der Nordic Society of Paediatric Haematology and Oncology (NOPHO) gesponserten Phase-II-Studie, die das Potenzial von Eryaspase als Behandlungsoption für ALL-Patienten bestätigenEin zweiter Abstract der neuen Analyse, der die Populationspharmakokinetik von Eryaspase bei Patienten mit ALL oder Adenokarzinom des Pankreas unterstützt, wird ebenfalls vorgestelltLYON, Frankreich und CAMBRIDGE, Massachusetts, Nov. 05, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, hat heute bekannt gegeben, dass ein Abstract mit Ergebnissen aus der von der NOPHO gesponserten Phase-II-Studie...

Presentazione orale per discutere i risultati dello studio di fase 2 sponsorizzato dalla Nordic Society of Pediatric Haematology and Oncology (NOPHO), che confermano il potenziale di eryaspase come opzione di trattamento per la LLAVerrà inoltre presentato il secondo abstract della nuova analisi a supporto della farmacocinetica di popolazione di eryaspase in pazienti affetti da LLA o adenocarcinoma pancreaticoLIONE, Francia e CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq e Euronext: ERYP), un’azienda biofarmaceutica di ambito clinico che sviluppa terapie innovative incapsulando sostanze terapeutiche all’interno dei globuli rossi, ha annunciato oggi che un abstract dettagliato dei risultati dello studio di fase 2 sponsorizzato da NOPHO su eryaspase nei pazienti affetti da LLA è stato selezionato per la...

PORTLAND, Maine, Nov. 05, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, will report unaudited financial results for the quarter ended September 30, 2020 after the market closes on Thursday, November 12, 2020.The Company has scheduled a conference call the next morning, Friday, November 13, 2020, at 9:00 AM ET to review the results.Interested parties can access the conference call scheduled by the Company to review the full third quarter 2020 financial results by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET on Friday, November 13, 2020. A teleconference replay of the...